Maria Giuseppa Vitale

2.5k total citations
47 papers, 488 citations indexed

About

Maria Giuseppa Vitale is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Maria Giuseppa Vitale has authored 47 papers receiving a total of 488 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Oncology, 27 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Maria Giuseppa Vitale's work include Renal cell carcinoma treatment (18 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Cancer Genomics and Diagnostics (7 papers). Maria Giuseppa Vitale is often cited by papers focused on Renal cell carcinoma treatment (18 papers), Cancer Immunotherapy and Biomarkers (12 papers) and Cancer Genomics and Diagnostics (7 papers). Maria Giuseppa Vitale collaborates with scholars based in Italy, United States and Netherlands. Maria Giuseppa Vitale's co-authors include M. Cinausero, Debora Basile, Stephen T. Sonis, Lorenzo Calvetti, Paola Ermacora, Giuseppe Aprile, V. Fanotto, Giuseppe Parisi, Roberto Sabbatini and Cinzia Baldessari and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and International Journal of Molecular Sciences.

In The Last Decade

Maria Giuseppa Vitale

44 papers receiving 484 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Giuseppa Vitale Italy 12 322 232 121 83 61 47 488
Lorenzo Calvetti Italy 9 336 1.0× 361 1.6× 96 0.8× 82 1.0× 113 1.9× 23 566
Paola Ermacora Italy 10 292 0.9× 268 1.2× 62 0.5× 85 1.0× 39 0.6× 28 508
Celalettin Eroğlu Türkiye 12 132 0.4× 269 1.2× 55 0.5× 39 0.5× 74 1.2× 42 499
Nikhil Uppal United States 6 120 0.4× 291 1.3× 82 0.7× 42 0.5× 87 1.4× 13 494
Roland Kurdow Germany 11 395 1.2× 224 1.0× 167 1.4× 37 0.4× 56 0.9× 22 699
Jiwang Liang China 14 195 0.6× 122 0.5× 155 1.3× 76 0.9× 108 1.8× 24 658
Masato Kataoka Japan 12 200 0.6× 193 0.8× 68 0.6× 25 0.3× 45 0.7× 51 411
Hiroo Imai Japan 12 94 0.3× 165 0.7× 110 0.9× 19 0.2× 38 0.6× 45 385

Countries citing papers authored by Maria Giuseppa Vitale

Since Specialization
Citations

This map shows the geographic impact of Maria Giuseppa Vitale's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Giuseppa Vitale with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Giuseppa Vitale more than expected).

Fields of papers citing papers by Maria Giuseppa Vitale

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Giuseppa Vitale. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Giuseppa Vitale. The network helps show where Maria Giuseppa Vitale may publish in the future.

Co-authorship network of co-authors of Maria Giuseppa Vitale

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Giuseppa Vitale. A scholar is included among the top collaborators of Maria Giuseppa Vitale based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Giuseppa Vitale. Maria Giuseppa Vitale is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pipitone, Stefania, et al.. (2024). Homologous Recombination Repair Deficiency in Metastatic Prostate Cancer: New Therapeutic Opportunities. International Journal of Molecular Sciences. 25(9). 4624–4624. 1 indexed citations
2.
Pipitone, Stefania, et al.. (2024). New Advances in Metastatic Urothelial Cancer: A Narrative Review on Recent Developments and Future Perspectives. International Journal of Molecular Sciences. 25(17). 9696–9696. 4 indexed citations
3.
Baldessari, Cinzia, Stefania Pipitone, Maria Giuseppa Vitale, et al.. (2024). Molecular characterization as new driver in prognostic signatures and therapeutic strategies for endometrial cancer. Cancer Treatment Reviews. 126. 102723–102723. 4 indexed citations
4.
Baldessari, Cinzia, Stefania Pipitone, Giuseppe Pugliese, et al.. (2023). Bone Metastases and Health in Prostate Cancer: From Pathophysiology to Clinical Implications. Cancers. 15(5). 1518–1518. 18 indexed citations
5.
Baldessari, Cinzia, et al.. (2023). De Novo Metastatic Prostate Cancer: Are We Moving toward a Personalized Treatment?. Cancers. 15(20). 4945–4945. 10 indexed citations
6.
Caruso, Giuseppe, Amelia Barcellini, Roberta Mazzeo, et al.. (2023). Vulvar Paget’s Disease: A Systematic Review of the MITO Rare Cancer Group. Cancers. 15(6). 1803–1803. 8 indexed citations
7.
Baldessari, Cinzia, Elena Zunarelli, Stefania Pipitone, et al.. (2023). Cerebellar metastasis of ovarian cancer: a case report. Journal of Medical Case Reports. 17(1). 553–553. 3 indexed citations
8.
Barcellini, Amelia, Tullio Golia D’Augè, Vincenzo Dario Mandato, et al.. (2023). Primary neuroendocrine neoplasms of the vulva: A review of the MITO rare cancer group. Critical Reviews in Oncology/Hematology. 193. 104201–104201. 1 indexed citations
9.
Mastrolia, Ilenia, Stefania Pipitone, Maria Giuseppa Vitale, et al.. (2023). Chasing the Role of miRNAs in RCC: From Free-Circulating to Extracellular-Vesicle-Derived Biomarkers. Biology. 12(6). 877–877. 2 indexed citations
10.
Vitale, Maria Giuseppa, Anna Crispo, Francesco Habetswallner, et al.. (2022). Survival analyses of the ZeOxaNMulti trial: Follow-up randomized, double-blinded, placebo-controlled trial of oral PMA-zeolite to prevent chemotherapy-induced side effects, especially peripheral neuropathy. Frontiers in Pharmacology. 13. 874028–874028. 1 indexed citations
12.
Vitale, Maria Giuseppa, et al.. (2021). Cabozantinib and nivolumab as first-line treatment in advanced renal cell carcinoma. Expert Review of Anticancer Therapy. 21(11). 1183–1192. 1 indexed citations
13.
Sabbatini, Roberto, et al.. (2021). Long progression-free survival with cabozantinib in a heavily pretreated patient with metastatic renal cell carcinoma: a case report. Tumori Journal. 107(6). NP33–NP36. 1 indexed citations
14.
Pipitone, Stefania, Maria Giuseppa Vitale, Cinzia Baldessari, Massimo Dominici, & Roberto Sabbatini. (2021). Long survival of a young patient with Xp11.2 translocation metastatic clear cell renal carcinoma: case report. Tumori Journal. 107(6). NP131–NP135. 2 indexed citations
15.
Masini, Cristina, Gabriele Carlinfante, Cinzia Iotti, et al.. (2021). Programmed death ligand-1 (PD-L1) expression in patients (pts) with metastatic renal cell carcinoma (mRCC) treated with nivolumab (NIVO) in combination with stereotactic body radiotherapy (SBRT) in NIVES study.. Journal of Clinical Oncology. 39(15_suppl). 4558–4558. 1 indexed citations
16.
Vitale, Maria Giuseppa, Anna Crispo, Francesco Habetswallner, et al.. (2020). ZeOxaNMulti Trial: A Randomized, Double-Blinded, Placebo-Controlled Trial of Oral PMA-Zeolite to Prevent Chemotherapy-Induced Side Effects, in Particular, Peripheral Neuropathy. Molecules. 25(10). 2297–2297. 11 indexed citations
18.
Fontanella, Caterina, Amelia Barcellini, Maria Giuseppa Vitale, et al.. (2017). Is chemotherapy worthwhile in patients with high-risk, lymph node negative, FIGO stage 1, endometrial cancer?. Annals of Oncology. 28. vi70–vi70. 1 indexed citations
20.
Riccardi, Ferdinando, et al.. (2014). Pancreatic solitary and synchronous metastasis from breast cancer: a case report and systematic review of controversies in diagnosis and treatment. World Journal of Surgical Oncology. 12(1). 2–2. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026